Donald Ansert, D.P.M.
Foot & Ankle Surgery Podiatrist in New Albany, Indiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,920 in Foot & Ankle Surgery Podiatrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Donald Ansert, D.P.M. reported a CMS MIPS final score of 98.7/100 - above the 83.1 national average - and filed 747 Medicare Part D claims in 2023.
- 98.7/100
- MIPS score · +16 vs avg
- 747
- Part D claims, 2023
- 94%
- generic prescribing
- $2.7K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Donald Ansert, D.P.M.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
99 Top 11% higher than 89% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Donald Ansert, D.P.M. sits
This provider among foot & ankle surgery podiatrist peers
Across the 3,155 foot & ankle surgery podiatrist providers who report both Medicare Part D prescribing and a MIPS quality score, Donald Ansert, D.P.M. writes more Part D claims than 92% of them and scores higher on MIPS quality than 94% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one foot & ankle surgery podiatrist peer from a representative sample of 60; the gold marker is Donald Ansert, D.P.M.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Donald Ansert, D.P.M.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Indiana
How Foot & Ankle Surgery Podiatrist compares to other specialties among Indiana providers
Foot & Ankle Surgery Podiatrist ranks #70 among Indiana's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the Indiana provider total, by primary NUCC taxonomy. The highlighted bar is Foot & Ankle Surgery Podiatrist; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Donald Ansert, D.P.M.'s 2023 MIPS final score plotted against the Foot & Ankle Surgery Podiatrist national average
- MIPS Final Score
- 98.7/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Foot & Ankle Surgery Podiatrist) - 98.7/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Foot & Ankle Surgery Podiatrist US NPIs
98.7/100 MIPS final score - 15.6 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Foot & Ankle Surgery Podiatrist. Quality dim: 97.4.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Donald Ansert, D.P.M. appears in the CMS NPPES registry as a Foot & Ankle Surgery Podiatrist provider holding D.P.M. credentials at 2315 GREEN VALLEY RD STE 200, New Albany, IN, 47150, with a listed phone of (812) 949-1002. NPI 1508838939 was issued on 02/01/2006.
Medicare Part D records for calendar year 2023 show 747 prescription claims written by this provider, covering 358 Medicare beneficiaries and totaling roughly $34K in drug spend, split 6% brand-name and 94% generic by claim count, with an opioid prescribing rate of 4.6%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 98.7/100 for the 2023 performance year (Quality 97.4), compared with the national average of 83.1.
Foot & Ankle Surgery Podiatrist is a mid-sized specialty nationwide, with 8,920 enrolled providers across 53 states and an average of 309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1508838939 |
|---|---|
| Specialty | Foot & Ankle Surgery Podiatrist |
| Credentials | D.P.M. |
| Gender | Male |
| NPI Issued | 02/01/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Donald Ansert, D.P.M.'s current license status, disciplinary history, and board certifications with the Indiana Medical Licensing Board in Indiana before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1508838939 is the unique 10-digit identifier CMS uses to link Ansert across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Hospital and facility affiliations
Facilities where Donald Ansert, D.P.M. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Donald Ansert, D.P.M.. Source: openpaymentsdata.cms.gov.
Total received
$2.7K
Largest payer
Stryker Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
6% brand-name claims vs 94% generic, on 747 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,150
- Total Day Supply
- 27,770
- Brand vs Generic
- 6% brand / 94% generic
- Brand Drug Cost
- $17K
- Generic Drug Cost
- $17K
- Opioid Claims
- 34 (4.6% rate)
- Antibiotic Claims
- 151
Patient Demographics
- Average Patient Age
- 72.0 years
- Avg HCC Risk Score
- 1.57
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 51, 65-74: 163, 75-84: 109, 85+: 35
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Donald Ansert, D.P.M. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Mupirocin
Mupirocin
126 claims
- Terbinafine Hcl
Terbinafine Hcl
126 claims
- Ammonium Lactate
Ammonium Lactate
84 claims
- Meloxicam
Meloxicam
64 claims
- Doxycycline Hyclate 40
Doxycycline Hyclate
40 claims
- Ciclopirox 32
Ciclopirox
32 claims
- Amoxicillin 28
Amoxicillin
28 claims
- Hydrocodone-Acetam… 24
Hydrocodone-Acetaminophen
24 claims
| Drug | Claims |
|---|---|
| Mupirocin | 126 |
| Terbinafine Hcl | 126 |
| Ammonium Lactate | 84 |
| Meloxicam | 64 |
| Doxycycline Hyclate | 40 |
| Ciclopirox | 32 |
| Amoxicillin | 28 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 24 |
| Silver Sulfadiazine | 22 |
| Gabapentin | 20 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Foot & Ankle Surgery Podiatrist Overview
How Donald Ansert, D.P.M. fits within the Foot & Ankle Surgery Podiatrist landscape nationally.
Donald Ansert, D.P.M.'s 747 claims are above the specialty average of 309.
Nearby Foot & Ankle Surgery Podiatrist Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Ansert.
Compare Foot & Ankle Surgery Podiatrist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Indiana medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Foot & Ankle Surgery Podiatrist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Indiana
Frequently Asked Questions
What is Donald Ansert, D.P.M.'s specialty? ▼
How much does Donald Ansert, D.P.M. prescribe under Medicare Part D? ▼
What is Donald Ansert, D.P.M.'s Medicare quality score? ▼
Where is Donald Ansert, D.P.M. located? ▼
What is Donald Ansert, D.P.M.'s NPI number? ▼
Does Donald Ansert, D.P.M. prescribe more brand-name or generic drugs? ▼
Does Donald Ansert, D.P.M. prescribe opioids? ▼
How many Foot & Ankle Surgery Podiatrist providers are there in the US? ▼
What drugs does Donald Ansert, D.P.M. prescribe most often? ▼
Does Donald Ansert, D.P.M. accept Medicare? ▼
How can I verify Donald Ansert, D.P.M.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology